BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next CFO

by Benzinga Staff
May 25, 2011 9:25 AM | 16 seconds read |
BioCryst Pharmaceuticals, Inc. BCRX today announced the appointment of Mr. Thomas R. Staab, II as BioCryst's new Chief Financial Officer, effective July 1, 2011, and that Mr. Stuart R. Grant, BioCryst's current CFO, has agreed to extend his employment with the Company an additional month to June 30, 2011.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsManagementBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!